Author:
Duléry Rémy,Schmidt-Hieber Martin,Sharrack Basil
Abstract
AbstractNeurological complications of allogeneic hematopoietic cell transplantation are frequent and often highly challenging to manage. These complications can stem from various causes, including neurotoxic drugs, infectious pathogens, cerebrovascular illness, metabolic encephalopathy, hematological disease relapse, immune-mediated disorders, thrombotic microangiopathy, and post-transplant lymphoproliferative disorder. While many of these complications are transient, a substantial subset is potentially fatal. Therefore, prompt diagnosis and treatment, guided by a neurologist, can be crucial in reducing the risks of irreversible complications, impairment of the quality of life, and transplantation-related mortality.
Publisher
Springer International Publishing
Reference23 articles.
1. Abboud R, Wan F, Mariotti J, et al. Cytokine release syndrome after haploidentical hematopoietic cell transplantation: an international multicenter analysis. Bone Marrow Transplant. 2021;56:2763–70.
2. Ahmed Z, Schoen M, Rajeh N. Myasthenia gravis presenting as graft versus host disease after allogeneic blood stem cell transplant. Case Rep Hematol. 2018;2018:7296930.
3. Beitinjaneh A, McKinney AM, Cao Q, Weisdorf DJ. Toxic leukoencephalopathy following fludarabine-associated hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2011;17:300–8.
4. Cai X, Fu HX, Mo XD, Wang Y, et al. Comparison of hemorrhagic and ischemic stroke after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2020;55:2087–97.
5. Eberly AL, Anderson GD, Bubalo JS, McCune JS. Optimal prevention of seizures induced by high-dose busulfan. Pharmacotherapy. 2008;28:1502–10.